Argenx management to present at upcoming virtual investor conferences

April 28, 2021 breda, the netherlands – argenx (euronext & nasdaq: argx), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in the following upcoming conferences:
ARGX Ratings Summary
ARGX Quant Ranking